Home › Postpartum Depression › NCT07766161

Informing Implementation of a Circadian-Focused Intervention for Postpartum Depression

Who can join

Ages 18 and older · Women

Inclusion Criteria:

1. ≤ 6 months postpartum
2. EPDS score \>10

Exclusion Criteria:

1. Current or past-year substance use disorder
2. Lifetime history of bipolar disorder or psychotic disorder
3. Active suicidal intent
4. Retinal pathology or history of eye surgery
5. Current use of photosensitizing medications
6. Untreated sleep-disordered breathing, untreated restless legs syndrome, or narcolepsy
7. Psychotherapy or psychotropic medications started/dose changed in past month (psychotherapy started and/or current medication at stable dose ≥ 4 weeks are permitted)
8. Medical conditions contraindicated for mBLT (e.g., epilepsy/seizures)

About the study

The proposed study is an open-label trial of Re-Timer® wearable morning bright light therapy for postpartum depression. The study is focused on evaluating the feasibility, acceptability, and implementation context of morning Bright Light Treatment (mBLT) for postpartum depression.

What is being tested

• Light therapy (device)

Sponsor: University of Michigan · Participants: 30 · Started: Jul 29, 2026

Contact the study team

• Kelley DuBuc · Phone: 734-764-1904

Official record on ClinicalTrials.gov — NCT07766161

Locations in the U.S.

Conditions

• Postpartum Depression

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.